Clinical Trial Update: Safety and Effectiveness Study of Chemotherapy and Ziv-aflibercept to Treat Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 safety and effectiveness trial of chemotherapy plus ziv-aflibercept for metastatic colorectal cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Zaltrap (ramucirumab)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Colorectal Cancer, Metastatic Colorectal Cancer | Phase 2 | Status: WITHDRAWN